We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGRA.L Regulatory News (GRA)

  • There is currently no data for GRA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity re Share Stake Scheme

14 Dec 2020 15:45

RNS Number : 6071I
Grafenia plc
14 December 2020
 

14 December 2020

Grafenia plc

 

("Grafenia", "the Group" or "the Company")

 

Issue of Equity re Share Stake Scheme

 

Grafenia (AIM: GRA) announces the result of the Share Stake Scheme (the "Scheme"), details of which were announced on 28 April 2020.

 

The Scheme allowed team members to elect to forgo a proportion of their remuneration receivable from the Company, in return for the receipt of new ordinary shares of one penny each in the Company ("New Ordinary Shares").

 

A total of 919,032 New Ordinary Shares are to be issued in respect of the Scheme. Details of the final number of New Ordinary Shares to be issued to applicable Directors and their resulting shareholdings are set out below.

 

 

 

New Ordinary Shares to be issued

Resulting shareholding

% holding upon Admission

Conrad Bona

Non-Executive Director

83,580

1,170,007

1.02%

Simon Barrell

Non-Executive Director

85,356

85,356

0.07%

Peter Gunning

Chief Executive Officer

231,352

1,965,352

1.71%

Iain Brown

Group Finance Director

84,208

84,208

0.07%

Gavin Cockerill

Chief Operating Officer

87,644

92,518

0.08%

Richard Lightfoot

Director & Company Secretary

77,156

152,156

0.13%

 

Application for Admission

Application will be made for the 919,032 New Ordinary Shares being issued to be admitted to trading on AIM and it is expected that admission will take place on or around 18 December 2020 ('Admission').

 

Total Voting Rights

Upon Admission, the issued share capital of the Company will consist of 114,490,828 Ordinary Shares. The Company does not hold any shares in treasury. Therefore, the total number of voting rights in the Company from Admission will be 114,490,828. This figure may be used by shareholders as the denominator for the calculations by which they determine if they are required to notify their interest in or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

For further information:

Grafenia plc

 

 

 

Peter Gunning (CEO)

+44 7973 191 632

Jan Mohr (Chairman)

+49 175 734 2740

Iain Brown (Finance Director)

+44 161 848 5713

 

 

Allenby Capital Limited (Nominated Adviser and broker)

+44 203 328 5656

David Hart / Liz Kirchner

 

     

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEEASALFLLEFFA
Date   Source Headline
17th Oct 20237:00 amRNSChange of Company name effective
16th Oct 20236:30 pmRNSDirector/PDMR Shareholding
6th Oct 20239:37 amRNSGrant of options
26th Sep 202312:21 pmRNSResult of AGM and Change of Name and Website
21st Sep 20237:00 amRNSHolding(s) in Company
20th Sep 20235:39 pmRNSHolding(s) in Company
15th Sep 20235:47 pmRNSReplacement: Result of GM and Open Offer
15th Sep 202310:22 amRNSResult of General Meeting and Open Offer
8th Sep 20232:03 pmRNSDirector/PDMR Shareholding
29th Aug 20237:00 amRNSFundraise of up to £27.9 million and other matters
26th Jul 20237:00 amRNSFinal Results
1st Jun 20237:00 amRNSUpdate re. the sale of Works Manchester Limited
3rd May 20237:00 amRNSPre-close statement and Trading Update
3rd Apr 20231:13 pmRNSHolding(s) in Company
17th Feb 202312:35 pmRNSAcquisition of Topfloor Systems Limited
20th Jan 20232:49 pmRNSBond Issue
18th Jan 20237:00 amRNSAcquisition of Care Management Systems Limited
28th Dec 20227:00 amRNSHolding(s) in Company
13th Dec 20227:00 amRNSReplacement: Bond Issue
12th Dec 20225:51 pmRNSBond Issue
7th Dec 20225:07 pmRNSAcquisition of Watermark Technologies Limited
24th Nov 20227:00 amRNSHalf-year Report
31st Oct 20227:00 amRNSBoard Appointment
7th Oct 202211:37 amRNSHolding(s) in Company
6th Oct 20221:48 pmRNSHolding(s) in Company
27th Sep 202212:56 pmRNSBond Issue
22nd Sep 20224:09 pmRNSAcquisition of Vertical Plus Limited
14th Sep 20222:18 pmRNSResult of AGM
27th Jul 20223:18 pmRNSReplacement: Final Results
27th Jul 20227:00 amRNSFinal Results
19th May 20227:00 amRNSSale of Subsidiary and Board Changes
4th May 20229:01 amRNSDirector/PDMR Shareholding
6th Apr 202212:00 pmRNSPre-close statement and Trading Update
22nd Nov 20217:00 amRNSHalf-year Report
15th Sep 202110:35 amRNSResult of AGM
15th Sep 20217:00 amRNSAGM Trading Statement
28th Jul 20217:00 amRNSFinal Results
16th Apr 20217:00 amRNSPre-close Trading and Strategy Update
3rd Mar 20217:00 amRNSBlock admission review & block cancellation
8th Jan 202112:38 pmRNSStmnt re Share Price Movement
31st Dec 20201:00 pmRNSTotal Voting Rights
14th Dec 20203:45 pmRNSIssue of Equity re Share Stake Scheme
25th Nov 20207:00 amRNSHalf-year Report
22nd Sep 202011:31 amRNSResult of AGM
22nd Sep 20207:00 amRNSAGM Trading Statement and Acquisition Update
3rd Sep 20207:00 amRNSBlock listing Interim Review
1st Sep 20207:00 amRNSReplacement: Final Results
12th Aug 20207:00 amRNSFinal Results
24th Jul 202012:37 pmRNSReplacement: Bond Facility & trading update
15th Jul 202010:45 amRNSBond Facility for up to £50m & trading update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.